Short Summary
The appeal challenged a temporary injunction granted by the Trial Court, which restrained the defendant from displaying an advertisement for 'MOOV' that compared it to the plaintiff's product, ZANDU BALM. The High Court examined whether such comparative advertising amounted to disparagement of the plaintiff's trademark and copyright.
Detailed Summary
In the fiercely competitive world of over-the-counter pain relief, every advertisement is a battlefield. When one brand decides to directly compare its product against a market leader, the question becomes not just who wins the consumer's attention, but who wins in the courtroom. This case between two giants of the Indian healthcare and personal care industry, Reckitt Benckiser Health Care (India) and Emami Ltd, sits at the very intersection of commercial rivalry, free speech, and intellectual property protection. For founders and brand builders, it offers a masterclass in where the line is drawn between clever marketing and legal liability.
The dispute arose between two well-known players in the Indian consumer healthcare space. The plaintiff, Reckitt Benckiser Health Care (India), was the owner of the established and widely recognized brand 'ZANDU BALM', a product that had carved out a significant share of the market. The defendant, Emami Ltd, marketed a competing product known as 'MOOV'. The conflict was triggered when Emami aired an advertisement for MOOV that directly compared its product to ZANDU BALM. Reckitt Benckiser moved quickly, securing a temporary injunction from the Trial Court that restrained Emami from displaying the comparative advertisement, alleging that the ad disparaged its trademark and infringed its copyright. Aggrieved by this restraint, Emami approached the High Court, challenging the Trial Court's order.
Reckitt Benckiser argued that the MOOV advertisement went far beyond mere product comparison. They contended that the ad disparaged the goodwill and reputation built around the ZANDU BALM trademark, effectively tarnishing a brand they had carefully cultivated. They also raised concerns about copyright infringement, suggesting that the manner in which the comparison was drawn violated their exclusive rights over the creative elements associated with their product. On the other side, Emami defended the advertisement as legitimate comparative advertising, a recognized form of commercial speech. They argued that consumers benefited from being able to evaluate competing products side by side, and that the ad did not cross the threshold into disparagement. The legal friction centered on a fundamental tension: the right to commercial expression under Article 19(1)(a) of the Constitution versus the right of a trademark owner to protect their brand from being unfairly maligned.
The High Court sided with the defendant, Emami Ltd. After carefully examining the nature of the advertisement and the legal principles governing comparative advertising, the Court found that the Trial Court's temporary injunction could not be sustained. The Court reasoned that while comparative advertising enjoys a degree of constitutional protection under Article 19(1)(a), this protection is not absolute. However, in this instance, the Court determined that the advertisement did not surpass the permissible limits or amount to actionable disparagement of the plaintiff's trademark or copyright. The temporary injunction restraining Emami from airing the MOOV advertisement was set aside, allowing the comparative campaign to continue.
For founders, marketers, and IP professionals, this case delivers a clear and urgent lesson: comparative advertising is a powerful marketing tool, but it is not a legal shield. The moment your ad crosses from objective product comparison into subjective disparagement of a competitor's trademark or brand, you expose your company to injunctions, damages, and reputational risk. Before launching any ad that directly references a competitor, invest in rigorous legal review. Understand that free speech protections for commercial advertising have limits, and courts will intervene when a competitor's brand is unfairly targeted. Smart competition respects the line; reckless comparison pays for it in court.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Calcutta High Court (Appellete Side). Understanding the court's reasoning in Reckitt Benckiser Health Care (India) Pvt. vs Emami Ltd & Ors. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
Hindustan Aeronautics LimitedvsCommissioner of Central Excise Bangalore - I
The appeal challenged the imposition of service tax under the 'Intellectual Property Right' category on payments made by HAL to BAE System for technical knowhow and assistance related to aircraft manufacturing. The Tribunal ruled that since the contract involved a temporary transfer of technology, it did not fall under the definition of IPR services chargeable to service tax.
Ajay Alias Vishal Veeru DevganvsThe Artists Planet & Ors.
The Delhi High Court issued several procedural orders in the ongoing suit filed by Ajay Alias Vishal Veeru Devgan against The Artists Planet & Ors. The court granted exemptions to the plaintiff from mandatory pre-litigation mediation, citing the need for urgent interim relief. Furthermore, the court directed the production and inspection of documents by the defendants, while also formally registering the plaint as a civil suit seeking protection against trademark infringement, passing off, copyright violation, and misappropriation of personality rights.
M/S SUMOTEK INNOVATION PVT LTDvsAssam Power Distribution Co. Ltd
M/S Sumotek Innovation Pvt Ltd (Appellant No. 1) filed a suit seeking declaration of rights and permanent injunction against Assam Power Distribution Co. Ltd (Respondent No. 2) for using their patented technology (Patent No. 208216). The appeal challenged the Trial Court's rejection of the interim injunction application, which was based on lack of locus standi. The High Court dismissed the appeal, finding that while the appellant might have locus standi, they did not establish a prima facie case for an injunction due to the patent nearing its expiry.
Universitat UlmvsAssistant Controller of Patents and Designs, Government of India
Universitat Ulm appealed the rejection of its patent application (No. 645/CHENP/2011) concerning Opioids for Resistant Cancer Treatment. The High Court found the original order cryptic, noting that it failed to discuss prior arts or address specific submissions made by the appellant regarding synergistic effects and foreign patents. Consequently, the appeal was allowed, and the matter was remanded for fresh scrutiny.
UPL LimitedvsThe Controller Of Patents Designs And Ors
UPL Limited appealed a decision by the Joint Controller of Patents and Designs which refused to proceed with its patent application (No. 1378/KOL/2013). The appellant argued that the rejection was based on procedural flaws, specifically the failure to address expert affidavits and critical technical submissions. The Court set aside the impugned order based on admissions made by the authorities in their affidavit in opposition.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.